ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π½Π΅ΠΉΡΠΎΡΠ°Π΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΏΡΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΌ ΠΈ Π²ΡΠΎΡΠΈΡΠ½ΠΎΠΌ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅
ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ. ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ (ΠΠ€Π‘) ΠΈ Π΅Π³ΠΎ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ Ρ ΠΌΠΎΠΌΠ΅Π½ΡΠ° ΠΎΡΠΊΡΡΡΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π½Π°Ρ ΠΎΠ΄ΡΡΡΡ ΠΏΠΎΠ΄ ΠΏΡΠΈΡΡΠ°Π»ΡΠ½ΡΠΌ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ΠΌ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ². Π‘Π²ΡΠ·Π°Π½ΠΎ ΡΡΠΎ Ρ ΡΠ΅ΠΌ, ΡΡΠΎ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ Π΅Π³ΠΎ ΠΌΠ½ΠΎΠ³ΠΎΠΎΠ±ΡΠ°Π·Π½Ρ, Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π½Π°Ρ ΠΎΠ΄ΡΡΡΡ Π² ΠΊΠΎΠΌΠΏΠ΅ΡΠ΅Π½ΡΠΈΠΈ ΡΠΌΠ΅ΠΆΠ½ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ ΡΠΏΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ, ΡΠ°ΠΊΠΈΡ ΠΊΠ°ΠΊ ΡΠ΅Π²ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ, Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡ, Π½Π΅ΠΉΡΠΎΡ ΠΈΡΡΡΠ³ΠΈΡ, Π°ΠΊΡΡΠ΅ΡΡΡΠ²ΠΎ, ΡΠΎΡΡΠ΄ΠΈΡΡΠ°Ρ Ρ ΠΈΡΡΡΠ³ΠΈΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
ΠΠ»Π°Π²Π° 1. ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ. «ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ, ΠΈΡΡΠΎΡΠΈΡ Π²ΠΎΠΏΡΠΎΡΠ°. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π½Π΅ΡΠ²Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅ ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π½Π΅ΠΉΡΠΎΠ²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π² Π΅Π³ΠΎ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅».
1.1 ΠΠ±ΡΠΈΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΈ ΠΈΡΡΠΎΡΠΈΡ Π²ΠΎΠΏΡΠΎΡΠ°.
1.2 ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π½Π΅ΡΠ²Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅.
1.2.1 ΠΠ½ΡΡΠ»ΡΡ.
1.2.2 ΠΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ½ΡΠ°ΡΠΊΡΡ.
1.2.3 ΠΡΠ΅ΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ΅ΡΠ΅Π±ΡΠ°Π»ΡΠ½ΡΠΉ Π²Π΅Π½ΠΎΠ·Π½ΡΠΉ ΡΡΠΎΠΌΠ±ΠΎΠ·.
1.2.4 Π‘ΠΈΠ½Π΄ΡΠΎΠΌ Π‘Π½Π΅Π΄Π΄ΠΎΠ½Π° ΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ.
1.2.5 ΠΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ.
1.2.6 Π¦Π΅ΡΠ°Π»Π³ΠΈΡ.
1.2.7 ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΈ ΠΈΠ΄ΠΈΠΎΠΏΠ°ΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π²Π½ΡΡΡΠΈΡΠ΅ΡΠ΅ΠΏΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΡ.
1.2.8 ΠΠΎΠ³Π½ΠΈΡΠΈΠ²Π½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ.
1.2.9 ΠΠ΅ΠΌΠ΅Π½ΡΠΈΡ.
1.2.10 ΠΠΊΡΡΡΠ°ΠΏΠΈΡΠ°ΠΌΠΈΠ΄Π½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ.
1.2.11 ΠΡΠΈΡ ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ.
1.2.12 ΠΡΠ΅Ρ ΠΎΠ΄ΡΡΠ°Ρ Π³Π»ΠΎΠ±Π°Π»ΡΠ½Π°Ρ Π°ΠΌΠ½Π΅Π·ΠΈΡ.
1.2.13 ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΈ Π·ΡΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ.
1.2.14 Π‘Π²ΡΠ·Ρ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΡ Π°Π½ΡΠΈΡΠ΅Π» ΠΈ ΡΠ°ΡΡΠ΅ΡΠ½Π½ΠΎΠ³ΠΎ ΡΠΊΠ»Π΅ΡΠΎΠ·Π°.
1.2.15 ΠΠ΅ΠΉΡΠΎΡΠ΅Π½ΡΠΎΡΠ½Π°Ρ ΡΡΠ³ΠΎΡΡ ΠΎΡΡΡ ΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ.
1.2.16 ΠΠΎΠΏΠ΅ΡΠ΅ΡΠ½Π°Ρ ΠΌΠΈΠ΅Π»ΠΎΠΏΠ°ΡΠΈΡ.
1.2.17 Π‘ΠΈΠ½Π΄ΡΠΎΠΌ ΠΠΈΠΉΠ΅Π½Π°-ΠΠ°ΡΡΠ΅.
1.3 ΠΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π½Π΅ΡΠ²Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΡΠΈ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ ΠΊΡΠ°ΡΠ½ΠΎΠΉ Π²ΠΎΠ»ΡΠ°Π½ΠΊΠ΅.
1.4 ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π½Π΅ΡΠ²Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅ ΠΈ ΡΠΏΠΎΡΠΎΠ±Ρ Π°Π½Π°Π»ΠΈΠ·Π° ΠΈΠ·ΠΎΠ±ΡΠ°ΠΆΠ΅Π½ΠΈΠΉ.
ΠΠ»Π°Π²Π° 2. ΠΠ΅ΡΠΎΠ΄Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΈ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π°Π½Π°Π»ΠΈΠ·ΠΈΡΡΠ΅ΠΌΡΡ Π³ΡΡΠΏΠΏ Π±ΠΎΠ»ΡΠ½ΡΡ .
2.1 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° Π²ΠΊΠ»ΡΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΠΈΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΡ Π³ΡΡΠΏΠΏΡ ΠΈ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠ².
2.2 Π₯Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠ€Π‘ ΠΈ Π»ΠΈΡ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ.
2.3 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΊΡΠΎΠ²ΠΈ Π½Π° ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΈΠΏΠΈΠ½Ρ (ΠΠΠ) ΠΈ Π²ΠΎΠ»ΡΠ°Π½ΠΎΡΠ½ΠΎΠ³ΠΎ Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»ΡΠ½ΡΠ° (ΠΠ).
2.4 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° ΡΠ±ΠΎΡΠ° Π°Π½Π°ΠΌΠ½Π΅Π·Π° ΠΈ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ , Π²ΠΊΠ»ΡΡΠ΅Π½Π½ΡΡ Π² ΠΈΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΠ΅ Π³ΡΡΠΏΠΏΡ.
2.5 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.
2.5.1 Π₯Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠ² ΡΠΊΠ°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ.
2.5.2 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° ΠΎΡΠ΅Π½ΠΊΠΈ ΠΠ -ΡΠΎΠΌΠΎΠ³ΡΠ°ΠΌΠΌ.
2.5.3 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° ΠΎΡΠ΅Π½ΠΊΠΈ ΠΠ -Π°Π½Π³ΠΈΠΎΠ³ΡΠ°ΠΌΠΌ.
2.5.4 ΠΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΉ, ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΡ ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ.
2.6 ΠΠ΅ΡΠΎΠ΄ΠΈΠΊΠ° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ.
ΠΠ»Π°Π²Π° 3. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠΎΠ±ΡΡΠ²Π΅Π½Π½ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ.
ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅.
3.2 ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅.
3.3 ΠΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ Ρ Π΄ΡΡΠ³ΠΈΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ.
3.4 Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ.
3.5 Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ Π°Π½Π³ΠΈΠΎΠ³ΡΠ°ΡΠΈΠΈ.
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π° Π.Π‘. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π²ΠΎΠ»ΡΠ°Π½ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ°Π³ΡΠ»ΡΠ½ΡΠ° ΠΈ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΈΠΏΠΈΠ½Ρ Π’Π΅ΠΊΡΡ. / Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, .JI. ΠΠ°ΡΠΎΠ½ΠΎΠ², JI.3. ΠΡΡΠ΄Π½ΠΈΠΊΠΎΠ²Π°. // Π’Π΅Ρ. ΠΡΡ ΠΈΠ².- 1988.- β.7.- Π‘.84−86.
- ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π° Π.Π‘. ΠΡΡΡΡΠΉ ΠΏΠΎΠΏΠ΅ΡΠ΅ΡΠ½ΡΠΉ ΠΌΠΈΠ΅Π»ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ ΠΊΡΠ°ΡΠ½ΠΎΠΉ Π²ΠΎΠ»ΡΠ°Π½ΠΊΠΎΠΉ Π’Π΅ΠΊΡΡ. / Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, Π. Π. Π€ΠΎΠ»ΠΎΠΌΠ΅Π΅Π²Π° // Π’Π΅Ρ. ΠΡΡ ΠΈΠ².- 1991.-Π’.63, № 4.- Π‘. 110−113.
- ΠΠ½ΡΠΈΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΈΠΏΠΈΠ½ΠΎΠ²ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΏΡΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅ Π‘Π½Π΅Π΄Π΄ΠΎΠ½Π° Π’Π΅ΠΊΡΡ. / JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, ΠΠ. ΠΠ°ΡΠΎΠ½ΠΎΠ², Π. Π. ΠΡΡΠ΅ΠΊΠ±Π°Π΅Π²Π°, JI.A. ΠΡΠ°ΡΠ΅Π²Π° // ΠΠ΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡ.- 1990.-Π’.40, № 3.-Π‘.464−467.
- ΠΠ½ΡΠΈΡΠ΅Π»Π° ΠΊ ΠΏΡΠΎΡΡΠΎΠΌΠ±ΠΈΠ½Ρ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Π‘Π½Π΅Π΄Π΄ΠΎΠ½Π° Π’Π΅ΠΊΡΡ. / ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π° JI.A., ΠΠΎΡΡΡΠ½ Π. Π., Π¨Π°Π²ΠΈΡ Π‘., Π. Π Π΅Π±ΡΠΎΠ²Π°, Π’. Π Π΅ΡΠ΅ΡΠ½ΡΠΊ, ΠΠΆ. Π§Π°ΠΏΠΌΠ°Π½ // ΠΠ΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡ.- 1999.- Π’.53, № 1- Π‘.223−225.
- ΠΠ½ΡΠΈΡΠ΅Π»Π° ΠΊ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π°ΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ ΠΊΡΠ°ΡΠ½ΠΎΠΉ Π²ΠΎΠ»ΡΠ°Π½ΠΊΠΎΠΉ ΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΠΌ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Π’Π΅ΠΊΡΡ. / Π’. Π. Π Π΅ΡΠ΅ΡΠ½ΠΈΠ°ΠΊ, Π. ΠΠΎΠΉΡΠ΅Ρ ΠΎΠ²ΡΠΊΠ°Ρ, Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, Π. Π‘. ΠΠ°ΡΡ, Π. ΠΠ°Π±Π΅ΠΊ// ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 1999.- № 5.- Π‘.32−37.
- ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΏΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ΅Ρ ΡΠ΅ΡΠ° Π’Π΅ΠΊΡΡ. / Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, Π’. Π. ΠΡΠΎΠΊΠ°Π΅Π²Π°, Π’. Π. Π Π΅ΡΠ΅ΡΠ½ΡΠΊ, E.H. ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π°, E.JI. ΠΠ°ΡΠΎΠ½ΠΎΠ² // ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 2000.- № 5. Π‘.37−38.
- ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ Ρ Ρ ΠΎΡΠ΅ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡΠΌΠΈ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠΎΠ»ΡΠ±Π΅Π²Π°, A.A. Π‘ΡΡΡΡΠ΅Π½ΠΊΠΎ, Π. Π. Π‘ΠΎΠ»ΠΎΠ²ΡΠ΅Π²Π°, E.H. ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π°, Π. Π‘. Π¨Π²Π°ΡΠ΅Π²Π°, A.M. ΠΠ΅ΠΈΠ½ // Π. ΠΠ΅Π²ΡΠΎΠΏΠ°Ρ. ΠΡΠΈΡ ΠΈΠ°ΡΡ, ΠΈΠΌ. Π‘. Π‘. ΠΠΎΡΡΠ°ΠΊΠΎΠ²Π°.- 2000.-№ 6.- Π‘.89−92.
- ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ ΠΏΡΠΈΠ²ΡΡΠ½ΡΠΌ ΠΏΡΠ΅ΡΡΠ²Π°Π½ΠΈΠ΅ΠΌ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ Π’Π΅ΠΊΡΡ. / JI.A. ΠΡΡΡΠΎΠ²Π°, Π. Π. ΠΠ΅ΡΠ½ΡΠΊ, Π. Π. ΠΡΡΠΈΠ»ΠΎΠ²Π°, Π. Π. Π Π΅ΠΌΠΈΠ·ΠΎΠ²Π° // ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 1999.- № 7.- Π‘.43−46.
- ΠΠ°ΡΠΊΠ°Π³Π°Π½ Π.Π‘. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΡΠ΅ΠΌΠ°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π³Π΅ΠΌΠΎΡΡΠ°Π·Π° Π’Π΅ΠΊΡΡ. / Π. Π‘. ΠΠ°ΡΠΊΠ°Π³Π°Π½, Π. Π. ΠΠ°ΠΌΠΎΡ Π.: ΠΡΠΎΠ΄ΠΈΠ°ΠΌΠ΅Π΄, 2001.218 Ρ.
- ΠΠΎΠ»Π΄ΡΡΠ΅Π² Π.Π. ΠΠΏΠΈΠ»Π΅ΠΏΡΠΈΡ Ρ Π²Π·ΡΠΎΡΠ»ΡΡ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠΎΠ»Π΄ΡΡΠ΅Π² Π.: ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°, 1984.- 288 Ρ.
- ΠΠ°Π±Π°ΡΠ²ΠΈΠ»ΠΈ Π.Π. ΠΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΈΠΏΠ°Π΄ΠΊΠΈ ΠΏΡΠΈ ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΡ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°Π±Π°ΡΠ²ΠΈΠ»ΠΈ, Π. Π‘. ΠΡΠΎΡ ΠΎΡΠΎΠ²Π°, P.P. Π¨Π°ΠΊΠ°ΡΠΈΡΠ²ΠΈΠ»ΠΈ -Π’Π±ΠΈΠ»ΠΈΡΠΈ, ΠΠ΅ΡΠ½ΠΈΠ΅ΡΠ΅Π±Π°, 1986.- 337 Ρ.
- ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π° JI.A. ΠΠ΅ΡΠ²ΠΈΡΠ½ΡΠΉ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΈ ΡΠ΅ΡΠ΅Π±ΡΠΎΠ²Π°ΡΠΊΡΠ»ΡΡΠ½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ Π’Π΅ΠΊΡΡ. / JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π° // Π. ΠΠ΅Π²ΡΠΎΠΏΠ°Ρ. ΠΡΠΈΡ ΠΈΠ°ΡΡ, ΠΈΠΌ. Π‘. Π‘. ΠΠΎΡΡΠ°ΠΊΠΎΠ²Π°.- 2005.-Π’.105, № 5.- Π‘.11−16.
- ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π° JI.A. ΠΠ΅ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΠΌ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Π’Π΅ΠΊΡΡ. / JLA. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π° // Π. ΠΠ΅Π²ΡΠΎΠΏΠ°Ρ. ΠΡΠΈΡ ΠΈΠ°ΡΡ, ΠΈΠΌ. Π‘. Π‘. ΠΠΎΡΡΠ°ΠΊΠΎΠ²Π°.- 2005.-Π’.105, № 2, — Π‘. 18−23.
- ΠΠ°ΠΌΡΠ½ΠΎΠ² Π.Π. ΠΡΠ΅ΡΠΎΡΠΊΠ»Π΅ΡΠΎΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΏΠΈΠ»Π΅ΠΏΡΠΈΡ (Π²ΠΎΠΏΡΠΎΡΡ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°, ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΈ, Π»Π΅ΡΠ΅Π½ΠΈΡ). Π’Π΅ΠΊΡΡ.: Π΄Π½Π΅. ΠΊΠ°Π½Π΄. ΠΌΠ΅Π΄. Π½Π°ΡΠΊ: 14.00.13: Π·Π°ΡΠΈΡΠ΅Π½Π° 13.10.1969: ΡΡΠ². 1969 / ΠΠ°ΠΌΡΠ½ΠΎΠ² Π.Π.- Π ΠΈΠ³Π°, 1969.- 164 Ρ.
- ΠΠ°ΠΌΡΠ½ΠΎΠ² Π.Π. ΠΡΠ΅ΡΠΎΡΠΊΠ»Π΅ΡΠΎΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΏΠΈΠ»Π΅ΠΏΡΠΈΡ (ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·, ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°, Π»Π΅ΡΠ΅Π½ΠΈΠ΅). Π’Π΅ΠΊΡΡ. / ΠΠ°ΠΌΡΠ½ΠΎΠ² Π.Π.- Π ΠΈΠ³Π°, ΠΠΈΠ½Π°ΡΠ½Π΅, 1972.- 254 Ρ.
- ΠΠ°ΡΠ»ΠΎΠ² Π.Π. ΠΠΏΠΈΠ»Π΅ΠΏΡΠΈΡ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°ΡΠ»ΠΎΠ² Π., ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°, 1990.336 Ρ.
- ΠΠ°ΡΠΎΠ½ΠΎΠ²Π° Π.Π. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅Π²ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ²Π°, Π.Π. ΠΡΡΠ°ΠΏΠ΅Π½ΠΊΠΎ-Π.: ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°, 1989.- 157 Ρ.
- ΠΠ΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠ³ΠΎ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Π’Π΅ΠΊΡΡ. / JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, JI.A. ΠΠΎΠ±ΡΡΠ½ΠΈΠ½Π°, E.H. ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π°, A.A. ΠΠΎΠ²ΠΈΠΊΠΎΠ² // Π. ΠΠ΅Π²ΡΠΎΠΏΠ°Ρ. ΠΡΠΈΡ ΠΈΠ°ΡΡ, ΠΈΠΌ. Π‘. Π‘. ΠΠΎΡΡΠ°ΠΊΠΎΠ²Π°.- 2005.- ΠΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ 13. Π‘.19−24.
- ΠΠΎΠ·Π΄Π½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ ΠΊΡΠ°ΡΠ½ΠΎΠΉ Π²ΠΎΠ»ΡΠ°Π½ΠΊΠΈ Ρ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ²Π°, Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, Π’. Π. Π Π΅ΡΠ΅ΡΠ½ΡΠΊ // Π’Π΅Ρ. ΠΡΡ ΠΈΠ².- 1997.-Π’.69, № 11.- Π‘.50−54
- ΠΡΠΎΠ³ΡΠ΅ΡΡΠΈΠ²Π½ΡΠΉ ΠΏΠ°ΡΠ°Π»ΠΈΡ ΠΈ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊ ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΈΠΏΠΈΠ½Ρ Π’Π΅ΠΊΡΡ. / JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, E.H. ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π°, A.C. ΠΠ°Π΄ΡΠΊΠΎΠ², E.JI. ΠΠ°ΡΠΎΠ½ΠΎΠ², JI.A. ΠΠΎΠ±ΡΡΠ½ΠΈΠ½Π°, Π. Π. Π Π΅Π²Π΅Π½ΠΎΠΊ, Π. Π. ΠΠ°ΡΠΈΠ½Π° // ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 2001.- № 4. Π‘.63−66.
- Π ΠΎΠ»Ρ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΡ Π°Π½ΡΠΈΡΠ΅Π» Π² ΠΎΠΊΠΊΠ»ΡΠ·ΠΈΠΈ ΡΠΎΡΡΠ΄ΠΎΠ² ΡΠ΅ΡΡΠ°ΡΠΊΠΈ ΠΏΡΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΡ Π³Π»Π°Π· Π’Π΅ΠΊΡΡ. / ΠΡΠΌΠ°ΠΊΠΎΠ²Π° H.A., ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π° Π. Π‘., ΠΠ°ΡΠΎΠ½ΠΎΠ² E. JL, ΠΠΎΡΠ΅Π»Π΅Π²Π° Π. Π., Π Π΅ΡΠ΅ΡΠ½ΡΠΊ Π’. Π., ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π° E.H. // ΠΠ΅ΡΡΠ½. ΠΡΡΠ°Π»ΡΠΌΠΎΠ»ΠΎΠ³ΠΈΠΈ.- 2002.- № 2.- Π‘.29−32.
- Π‘ΠΈΠ½Π΄ΡΠΎΠΌ «ΡΠ°ΡΡΠ΅ΡΠ½Π½ΠΎΠ³ΠΎ ΡΠΊΠ»Π΅ΡΠΎΠ·Π°» ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅ / JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, JI.A. ΠΠΎΠ±ΡΡΠ½ΠΈΠ½Π°, Π. Π. ΠΡΠΎΡΠ΅Π½ΠΊΠΎΠ²Π°, Π. Π ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π°, Π’. Π. Π Π΅ΡΠ΅ΡΠ½ΡΠΊ, A.B. ΠΠΎΠ²ΠΈΠΊΠΎΠ² // 10-Π°Ρ ΠΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΡ «ΠΠΠΠ ΠΠΠΠΠ£ ΠΠΠ ΠΠΠΠ―»: ΡΠ±. Π½Π°ΡΡ. ΡΡ., Π., 2001. Π‘. 15−20
- Π‘ΠΈΠ½Π΄ΡΠΎΠΌ Π‘Π½Π΅Π΄Π΄ΠΎΠ½Π° ΠΈ Π΅Π³ΠΎ ΡΠ²ΡΠ·Ρ Ρ Π°Π½ΡΠΈΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΈΠΏΠΈΠ½ΠΎΠ²ΡΠΌΠΈ Π°Π½ΡΠΈΡΠ΅Π»Π°ΠΌΠΈ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ², Π. Π. ΠΡΡΠ΅ΠΊΠ±Π°Π΅Π²Π°, Π.Π. ΠΡΠ°ΡΠ΅Π²Π°//ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 1988.- № 3.- Π‘.32−37.
- Π‘ΠΈΠ½Π΄ΡΠΎΠΌ Π‘Π½Π΅Π΄Π΄ΠΎΠ½Π° ΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΠΉ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ², Π. Π. Π‘ΡΠΎΡΠ½ΠΎΠ²ΠΈΡ, Π. Π. ΠΠΎΠ²Π°Π»Π΅Π², Π. Π. ΠΠΎΡΠ΅Π»Π΅Π²Π°, Π’. Π. Π Π΅ΡΠ΅ΡΠ½ΡΠΊ // Π’Π΅Ρ. ΠΡΡ ΠΈΠ².- 1993.-№ 3.- Π‘.64−70.
- Π‘ΠΈΠ½Π΄ΡΠΎΠΌ Π‘Π½Π΅Π΄Π΄ΠΎΠ½Π°: ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΡΠ΅ΡΠ΄ΡΠ° ΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° Π’Π΅ΠΊΡΡ. / Π. Π. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ², Π. Π. ΠΠΎΡΠΈΡΠ΅Π½ΠΊΠΎ, Π. Π. Π£ΡΠΌΠ°Π½, Π. Π. ΠΡΡΠ΄Π½ΠΈΠΊΠΎΠ²Π°, Π. Π£. ΠΠΎΠ²Π°Π»ΡΠ², Π. Π€. ΠΡΡΠ΅ΠΊΠ±Π°Π΅Π²Π° // ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.-1990 — Π’.68, № 6. Π‘.37−41
- Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ Π°ΡΡΠ΅ΡΠΈΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ ΠΊΡΠ°ΡΠ½ΠΎΠΉ Π²ΠΎΠ»ΡΠ°Π½ΠΊΠΎΠΉ Π’Π΅ΠΊΡΡ. / Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, Π. Π‘. ΠΠ°Ρ , Π. Π. ΠΠ΅ΡΠ°ΡΠΈΠΌΠΎΠ²Π°, Π’. Π. ΠΠΎΠΏΠΊΠΎΠ²Π°, Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ² // ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 2004.- № 4.- Π‘.46−49.
- Π‘ΠΏΠΈΡΠΈΠ½ H.H. ΠΠ½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΈ ΡΠ°ΡΡΠ΅ΡΠ½Π½ΡΠΉ ΡΠΊΠ»Π΅ΡΠΎΠ·: Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ-Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π’Π΅ΠΊΡΡ. / H.H. Π‘ΠΏΠΈΡΠΈΠ½,
- Π.Π. ΠΠΈΠ·ΠΎΠ²Π°, Π. Π. Π‘ΡΠ΅ΠΏΠ°Π½ΠΎΠ² // Π. ΠΠ΅Π²ΡΠΎΠΏΠ°Ρ. ΠΡΠΈΡ ΠΈΠ°ΡΡ, ΠΈΠΌ. Π‘. Π‘. ΠΠΎΡΡΠ°ΠΊΠΎΠ²Π°.- 2002.-Π’.42, ΠΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅.- Π‘.42−45.
- Π’ΡΠΎΠΌΠ±ΠΎ ΠΠ‘Π‘ Π² ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΠΏΡΠΈ Π°Π½ΡΠΈΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄Π½ΠΎΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅ Π’Π΅ΠΊΡΡ. / Π’. Π. Π Π΅ΡΠ΅ΡΠ½ΡΠΊ, Π. Π‘. ΠΠ°ΡΡ, Π. Π. ΠΠ»Π΅ΠΊΡΠ°Π½Π΄ΡΠΎΠ²Π°, JI.A. ΠΠ°Π»Π°ΡΠ½ΠΈΠΊΠΎΠ²Π°, Π. Π‘. ΠΠ»Π΅ΠΊΠ±Π΅ΡΠΎΠ²Π°, Π. Π. ΠΠ°ΡΠΎΠ½ΠΎΠ²Π° // ΠΠ»ΠΈΠ½. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°.- 1999.- № 10. Π‘.30−35.
- Π¨ΠΌΠΈΠ΄Ρ Π.Π. ΠΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠΉ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΈ ΡΠΏΠΈΠ½Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° Π’Π΅ΠΊΡΡ. / Π. Π. Π¨ΠΌΠΈΠ΄Ρ // Π. ΠΠ΅Π²ΡΠΎΠΏΠ°Ρ, ΠΈ ΠΡΠΈΡ ΠΈΠ°ΡΡ.-1985.-Π’.9.- Ρ.1281−1288.
- Π―ΠΊΡΠ±ΡΠΎΠ½ Π.Π. ΠΠΎΠΆΠ½ΠΎΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠ΅Π°ΠΊΡΠΈΡ ΠΠ°ΡΡΠ΅ΡΠΌΠ°Π½Π° Π’Π΅ΠΊΡΡ. / Π. Π. Π―ΠΊΡΠ±ΡΠΎΠ½ // ΠΠ΅ΡΡΠ½ΠΈΠΊ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ Π²Π΅Π½Π΅ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ.- 1957.- Π’.31, № 1.-Ρ.37−43.
- A case of primary antiphospholipid antibody syndrome with acute renal failure showing thrombotic microangiopathy Text. / S. Sakaguchi, K. Kitazawa, M. Watanabe, K. Mukai, D. Totsuka, T. Shibata, T. Sugisaki // Am. J Nephrol.- 1999.- P.594−598.
- Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI Text. / E.A. Ashton, C. Takahashi, M.J. Berg, A. Goodman, S. Totterman, S. Ekholm // J Magn Reson.Imaging.- 2003.-P.300−308.
- A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique Text. / M. Rovaris, M.L. Gawne-Cain, L. Wang, D.H. Miller //Neuroradiology.- 1997.- P. 161−165.
- Acute cerebellar ataxia of a patient with SLE Text. / M. Yaginuma, M. Suenaga, Y. Shiono, M. Sakamoto // Clin Neurol Neurosurg.- 2000.- P.37−39.
- Agah R. Fatal cerebral venous thrombosis as the initial manifestation of the antiphospholipid syndrome Text. / R. Agah, L. Rice, J. Winikates // Clin Neurol Neurosurg.- 1996.- Vol.98, № 2.- P. 189−191.
- Akiguchi I. Neuroradiologic and pathologic approaches to the diagnosis of dementia syndrome. [Text] / I. Akiguchi // Rinsho Shinkeigaku.- 1999.-Vol.39, № 1.- P. l 10−112.
- Al-Matar M. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood Text. / M. Al-Matar, J. Jaimes, P. Malleson //Neuropediatrics.- 2000.- Vol.31, № 2.- P. 107−108.
- A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus Text. / S. Menon, E. Jameson-Shortall, S.P. Newman, M.R. Hall-Craggs, R. Chinn, D.A. Isenberg // Arthritis Rheum.- 1999.- P.735−741.
- An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside Text. / S.E. Karpiak, S.P. Mahadik, L. Graf, M.M. Rapport // Epilepsia.- 1981.- P. 189−196.
- Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis Text. / K.S. Ginsburg, M.H. Liang, L. Newcomer, S.Z. Goldhaber, P.H. Schur, C.H. Hennekens, M.J. Stampfer // Ann Intern.Med.-1992.- P.997−1002.
- Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS) Text. / Neurology.- 1997.-Vol.48, № 1.- P.91−94.
- Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis Text. / J. Sastre-Garriga, J.C. Reverter, J. Font, M. Tintore, G. Espinosa, X. Montalban // Ann Neurol.- 2001.- P.408−411.
- Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group Text. / Initiative group //Neurology.- 1993.- Vol.43, № 10.- P.2069−2073.
- Anticardiolipin antibodies are an independent risk factor for ischemic stroke Text. / J. Zielinska, D. Ryglewicz, E. Wierzchowska, W. Lechowicz, D.B. Hier, A. Czlonkowska //Neurol Res.- 1999.- P.653−657.
- Anticardiolopin antibodies as a risk factor in stroke. [Text] / D.L.B.A.B.-M.Z. Krzesniak-Bohdan M // Wiad Lek.- 1998.- P.414−418.
- Anticardiolipin antibodies: a study in cerebral venous thrombosis Text. / R. Christopher, D. Nagaraja, N.S. Dixit, C.P. Narayanan // Acta Neurol Scand.1999.- P.121−124.
- Antiphospholipid antibodies in children with idiopathic cerebral ischaemia Text. / L. Angelini, A. Ravelli, R. Caporali, A. Martini // Lancet.- 1994.-P.1232−1234.
- Antiphospholipid antibodies: findings at arteriography Text. / J.M. Provenzale, D.P. Barboriak, N.B. Allen, T.L. Ortel // AJNR Am. J Neuroradiol.- 1998.-P.611−616.
- Antiphospholipid antibodies in acute Guillain-Barre syndrome Text. / E.N. Harris, H. Englert, G. Derve, G.R. Hughes, A. Gharavi // Lancet.- 1983.-P.1361−1362.
- Antiphospholipid antibodies in cerebral ischemia Text. / J. Montalban, A. Codina, J. Ordi, M. Vilardell, M.A. Khamashta, G.R. Hughes // Stroke.-1991.- P.750−753.
- Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood Text. / M. Schoning, R. Klein, I. Krageloh-Mann, M. Falck, S. Bien, P.A. Berg, R. Michaelis // Neuropediatrics.- 1994.- P.8−14.
- Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings Text. / J.M. Provenzale, E.R. Heinz, T.L. Ortel, B.G. Macik, L.A. Charles, M.J. Alberts // Radiology. -1994.- P.531−537.
- Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients Text. / A. Blohorn, E.
- Guegan-Massardier, A. Triquenot, Y. Onnient, F. Tron, J.Y. Borg, B. Mihout // Cerebrovasc Dis.- 2002.- P. 156−162.
- Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes Text. / J. Chapman, M. Cohen-Armon, Y. Shoenfeld, A.D. Korczyn//Lupus.- 1999.- P. 127−133.
- Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients Text. / M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. Dejonckheere, J. Raus // J Affect.Disord.- 1991.-P.133−140.
- A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus Text. / J.G. Hanly, C. Hong, S. Smith, J.D. Fisk // Arthritis Rheum.- 1999.- P.728−734.
- Asherson R.A. The catastrophic antiphospholipid syndrome Text. / R.A. Asherson // J Rheumatol.- 1992.- Vol. 19, № 4, — P.508−512.
- Asherson R.A. Antiphospholipid antibodies and chorea Text. / R.A. Asherson, G.R. Hughes // J Rheumatol.- 1988.- Vol.15, № 2.- P.377−379.
- Asherson R.A. Addison’s disease and primary antiphospholipid syndrome Text. / R.A. Asherson, G.R. Hughes // Lancet.- 1989.- Vol.2, № 8667.-P.874−878
- Asherson R.A. Recurrent deep vein thrombosis and Addison’s disease in «primary» antiphospholipid syndrome Text. / R.A. Asherson, G.R. Hughes // J Rheumatol.- 1989.- Vol.16, № 3.- P.378−380.
- A six year follow-up study on the influence of silent ischemic brain lesions on cognitive function and brain atrophy in elderly people. l[Text] / H. Oguro, K. Okada, S. Yamaguchi, S. Kobayashi //Nippon Ronen Igakkai Zasshi.- 2000.- P.298−303.
- Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus Text. / M.T. Herranz, G. Rivier, M.A. Khamashta, K.U. Blaser, G.R. Hughes // Arthritis Rheum.- 1994.- P.568−571.
- Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus Text. / E. Toubi, M.A. Khamashta, A. Panarra, G.R. Hughes // Am J Med.- 1995.- P.397−401.
- Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report Text. / N. Besbas, I. Damarguc, S. Ozen, S. Aysun, U. Saatci // Eur. J Pediatr.- 1994.-P.891−893.
- Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology Text. / E. Toussirot, D. Figarella-Branger, P. Disdier, J.R. Harle, P.J. Weiller // Clin Rheumatol.- 1994.- P.624−627.
- A study of periventricular hyperintensity. I. Normal brain aging Text. / K. Meguro, Y. Sekita, T. Yamaguchi, K. Yamada, T. Hishinuma, T. Matsuzawa//Arch Gerontol.Geriatr.- 1992.- P.183−191.
- A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Text. / D. Karussis, R.R. Leker, A. Ashkenazi, O. Abramsky // Ann.Neurol.- 1998.-P.629−634.
- Atrophy of the corpus callosum correlates with white matter lesions in patients with cerebral ischaemia Text. / K. Meguro, J.M. Constans, P. Courtheoux, J. Theron, F. Viader, A. Yamadori // Neuroradiology.- 2000.-P.413−419.
- Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies Text. / E. Toubi, J. Ben-David, A. Kessel, L. Podoshin, T.D. Golan // Lupus.- 1997.- P.540−542.
- Autoimmunity in depression: increased antiphospholipid autoantibodies Text. / M. Maes, H. Meitzer, J. Jacobs, E. Suy, J. Calabrese, B. Minner, J. Raus // Acta Psychiatr.Scand.- 1993.- P. 160−166.
- Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus Text. / R.A. Asherson, F. Liote, B. Page, O. Meyer, N. Buchanan, M.A. Khamashta, P. Jungers, G.R. Hughes // J Rheumatol.-1993.- P.284−288.
- Awada A. Leuko-araiosis and stroke: a case-control study Text. / A. Awada, M.F. Omojola // Acta Neurol Scand.- 1996.- Vol.94, № 6.- P.415−418.
- A young case with multi-infarct dementia associated with lupus anticoagulant Text. / A. Kurita, T. Hasunuma, S. Mochio, T. Shimada, Y. Isogai, T. Kurahashi //Intcm.Med.- 1994.- P.373−375.
- Bacon P.A. Vasculitis associated with connective tissue disorders Text. / P.A. Bacon, D.M. Carruthers // Rheum Dis Clin North Am.- 1995.- Vol.21, № 4.- P. 1077−1096.
- Barkhof F. Imaging of white matter lesions Text. / F. Barkhof, P. Scheltens // Cerebrovasc Dis.- 2002.- Vol.13 Suppl 2, № 21−30.
- Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Text. / G. Orefice, J.G. De, M. Coppola, V. Brancaccio, P.R. Ames // Lupus.- 1995.- P.324−326.
- Bernardino J.I. Cerebral magnetic resonance imaging (MRI) in patients with SLE and APS / Bernardino J.I., Mora M., and Novo S. // 10th International congress on Antiphospholipid Antibodies: materials of.- Sicily, — 2002. C. 276−277.
- Blank M. Bacterial induction of autoantibodies to iI2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome Text. / M. Blank, I. Krause // J Clin Invest.- 2002.- Vol.109, № 6.- P.797−804.
- Blaustein D.A. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis Text. / D.A. Blaustein, S.A. Blaustein // J Rheumatol.- 1998.- Vol.25, № 4.- P.798−800.
- Bogousslavsky J. Cerebrovascular diseases, 1991. [Text] / J. Bogousslavsky // Rev. Med Suisse Romande.- 1992.- Vol.112, № 7.- P.597−600.
- Bogousslavsky J. Intracranial large-artery disease and «lacunar» infarction Text. / R.F.M.P. Bogousslavsky J // Cerebrovasc Dis.- 1991.- Vol.l.-P.154−159.
- Boiten J. Two clinically distinct lacunar infarct entities? A hypothesis Text. / J. Boiten, J. Lodder, F. Kessels // Stroke.- 1993.- Vol.24, № 5.-P.652−656.
- Bokura H. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study Text. / H. Bokura, S. Kobayashi, S. Yamaguchi // J Neurol.- 1998.-Vol.245, № 2, — P. l 16−122.
- Borrelia burgdorferi infection with bilateral optic neuritis and intracerebral demyelinization lesions. [Text] / A.A. Bialasiewicz, W. Huk, K.F. Druschky, G.O. Naumann // Klin.Monatsbl.Augenheilkd.- 1989.- P.91−94.
- Brenner B. Symptomatic antiphospholipid antibody after neuroleptic drugs. [Text] /B. Brenner, L. Metz//Harefuah.- 1995.-Vol.128, № 7.- P.416−417.
- Brey R.L. Neurological manifestations of antiphospholipid antibody syndrome Text. / R.L. Brey, A. Escalante // Lupus.- 1998.- Vol.7 Suppl 2, βS67-S74.
- Briley D.P. Neurological disease associated with antiphospholipid antibodies Text. / D.P. Briley, B.M. Coull, S.H. Goodnight, Jr. // Ann.Neurol.- 1989.- Vol.25, № 3.- P.221−227.
- Bruyn G.A. Controversies in lupus: nervous system involvement Text. / G.A. Bruyn // Annals of the Rheumatic Diseases.- 1−3-1995.- Vol.54, № 3,-P. 159−167.
- Budd-Chiari syndrome associated with systemic lupus erithematosus: diagnostic imaging and percutaneous treatment Text. / R. Rizzati, S. Sala, M. Tilli, I. Marri, R. Galeotti // Radiol. Med (Torino).- 2003.- P.519−523.
- Budd-Chiari syndrome in a patient with the lupus anticoagulant Text. / C. Pomeroy, R.G. Knodell, W.R. Swaim, P. Arneson, M.L. Mahowald // Gastroenterology.- 1984.- P.158−161.
- Calmon G. Automatic measurement of changes in brain volume on consecutive 3D MR images by segmentation propagation Text. / G. Calmon, N. Roberts // Magn Reson.Imaging.- 2000.- Vol.18, № 4.- P.439−453.
- Canoso R.T. Neuroleptic-associated autoantibodies. A prevalence study Text. / R.T. Canoso, R.M. De Oliveira, R.A. Nixon // Biol Psychiatry.- 154−1990.- Vol.27, № 8.- P.863−870.
- Carbamazepine-induced systemic lupus erythematosus presenting as cardiac tamponade Text. / S.P. Verma, N. Yunis, A. Lekos, R.S. Crausman // Chest.- 2000.- P.597−598.
- Carhuapoma J.R. Cerebral venous thrombosis and anticardiolipin antibodies Text. / J.R. Carhuapoma, P. Mitsias, S.R. Levine // Stroke.- 1997.- Vol.28, № 12.- P.2363−2369.
- Central nervous system involvement in the antiphospholipid (Hughes) syndrome Text. / G. Sanna, M.L. Bertolaccini, M.J. Cuadrado, M.A. Khamashta, G.R. Hughes//Rheumatology.(Oxford).- 2003.- P.200−213.
- Cerebral atrophy in systemic lupus erythematosus: steroid- or disease-induced phenomenon? Text. / S.G. Ostrov, R.M. Quencer, N.B. Gaylis, R.D. Altman // AJNR Am J Neuroradiol.- 1982.-P.21−23.
- Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome Text. / R. Hilker, A. Thiel, C. Geisen, J. Rudolf// Lupus.- 2000.- P.311−316.
- Cerebral infarction in systemic lupus: association with anticardiolipin antibodies Text. / E.N. Harris, A.E. Gharavi, R.A. Asherson, M.L. Boey, G.R. Hughes // Clin Exp Rheumatol.- 1984.- P.47−51.
- Cerebral ischemia associated with anticardiolipin antibodies Text. / M. Vrethem, J. Ernerudh, F. Lindstrom, J.E. Olsson // Acta Neurol Scand.-1992.- P.412−417.
- Cerebral venous sinus thrombosis and antiphospholipid antibodies Text. / M.D. Boggild, R.V. Sedhev, D. Fraser, J.R. Heron // Postgraduate Medical Journal.- 1995.- P.487−489.
- Cerebral venous thrombosis and chronic active hepatitis as part of the antiphospholipid syndrome Text. / A. Kesler, I.S. Pomeranz, M. Huberman, B. Novis, E. Kott // Postgrad.Med.J.- 1996.- P.690−692.
- Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases Text. / S.R. Levine, M.J. Deegan, N. Futrell, K.M. Welch //Neurology.- 1990.- P. l 181−1189.
- Chorea and antiphospholipid antibodies: treatment with methotrexate Text. / S. Paus, B. Potzsch, J.H. Risse, T. Klockgether, U. Wullner // Neurology.- 2001.- P.137−138.
- Chorea gravidarum: a case report Text. / A.Y. Karageyim, B. Kars, R. Dansuk, E. Aygun, O. Unal, M.C. Turan // J Matern. Fetal Neonatal Med.-2002.- P.353−354.
- Chorea in primary antiphospholipid syndrome Text. / C. Masala, S. Morino, P. Zangari, G. Antonini // Clin. Neurol Neurosurg.- 1996.- P.247−248.
- Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies Text. / M.A. Khamashta, A. Gil, B. Anciones, P. Lavilla, M.E. Valencia, V. Pintado, J.J. Vazquez // Ann. Rheum Dis.- 1988.- P.681−683.
- Classification of Sneddon’s syndrome Text. / S.M. Schellong, K. Weissenborn, J. Niedermeyer, J. Wollenhaupt, M. Sosada, C. Ehrenheim, D. Lubach//Vasa.- 1997.-P.215−221.
- Clinical and neuroradiological aspects of Sneddon’s syndrome and primary antiphospholipid antibody syndrome. A follow-up study Text. / V. Fetoni, M. Grisoli, A. Salmaggi, R. Carriero, F. Girotti // Neurol Sci.- 2000.- P. 157 164.
- Clinical significance of brain white matter hyperintensities in young adults with psychiatric illness Text. / J.L. Breeze, D.C. Hesdorffer, X. Hong, J.A. Frazier, P.F. Renshaw // Harv.Rev.Psychiatry.- 2003.- P.269−283.
- Clinical significance of MRI white matter lesions in the elderly Text. / A.L. Hunt, W.W. Orrison, R.A. Yeo, K.Y. Haaland, R.L. Rhyne, P.J. Garry, G.A. Rosenberg // Neurology.- 1989.- P.1470−1474.
- CNS involvement in systemic lupus erythematosus: a case with remarkable histopathological findings Text. / M.J. Rood, J.F. Haverman, S.G. van Duinen, F.C. Breedveld, J.J. Verschuuren, T.W. Iluizinga // Ann Rheum Dis.- 2001.- P.299−300.
- Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis Text. / M.A. Deschiens, J. Conard, M.H. Horellou, A. Ameri, M. Preter, F. Chedru, M.M. Samama, M.G. Bousser// Stroke.- 1996.- P.1724−1730.
- Cognitive deficits in systemic lupus erythematosus Text. / S.D. Denburg, J.A. Denburg, R.M. Carbotte, J.D. Fisk, J.G. Hanly // Rheum Dis Clin North Am.- 1993.- P.815−831.
- Cognitive impairment and autoantibodies in systemic lupus erythematosus Text. / J.G. Hanly, N.M. Walsh, J.D. Fisk, B. Eastwood, C. Hong, G. Sherwood, J.V. Jones, E. Jones, K. Elkon // Br J Rheumatol.- 1993.- P.291−296.
- Cognitive impairment in patients with systemic lupus erythematosus Text. / J.G. Hanly, J.D. Fisk, G. Sherwood, E. Jones, J.V. Jones, B. Eastwood // J Rheumatol.- 1992.- P.562−567.
- Coincident arterial and venous cerebral thrombosis in primary antiphospholipid syndrome. [Text] / E. Keller, T. Sommer, G. Lutterbey, H.H. Schild // Rofo.- 1996.- P.300−302.
- Conley C.L. Haemorrhagic disorder caused by circulating anticoagulant in patients with dissiminated lupus erythematosus. Text. / C.L. Conley, R.C. Hartmann // J.Clin.Invest.- 1952.- Vol.3, № 621−622.
- Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA Text. / J. Valk, R.G. de Siegte, F.C. Crezee, G.J. Hazenberg, S.I. Thjaha, J.J. Nauta // Acta Radiol.- 1987.- P.659−665.
- Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures Text. / K. Wada, N. Yamada, T. Sato, H. Suzuki, M. Miki, Y. Lee, K. Akiyama, S. Kuroda // Psychosomatics.- 2001.-P.461−466.
- Cryptogenic partial epilepsies with anti-GMl antibodies: a new form of immune-mediated epilepsy? Text. / F. Bartolome!, J. Boucraut, M. Barrie, J. Kok, C. Dravet, D. Viallat, D. Bernard, J.L. Gastaut // Epilepsia.- 1996.-P.922−926.
- CT findings in chronic cerebrovascular insufficiency (author's transl). [Text] / V. Cosi, A. Cecchini, M. Poloni, F. Rognone, M. Ceroni, A. Martelli, L. Gozzoli //Riv.Patol.Nerv.Ment.- 1980.- P.87−93.
- Daif A.K. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis Text. / A.K. Daif// Funct.Neurol.- 1998.- Vol.13, № 4.-P.285−289.
- DeAngelis L.M. Primary central nervous system lymphoma imitates multiple sclerosis Text. / L.M. DeAngelis // J Neurooncol.- 1990.- Vol.9, № 2.- P. 177−181.
- Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus Text. / A. Cederholm, E. Svenungsson, K. Jensen-Urstad, C. Trollmo, A.K.
- Ulfgren, J. Swedenborg, G.Z. Fei, J. Frostegard // Arterioscler.Thromb.Vasc.Biol.- 2005.- P. 198−203.
- Dementia and antiphospholipid antibodies Text. / A. Mosek, I. Yust, T.A. Treves, N. Vardinon, A.D. Korczyn, J. Chapman // Dement.Geriatr.Cogn Disord.- 2000.- P.36−38.
- Denburg S.D. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus Text. / S.D. Denburg, J.A. Denburg // Lupus.- 2003.- Vol.12, № 12.- P.883−890.
- Devic’s neuromyelitis optica: study of nine cases Text. / L. Fardet, T. Genereau, Y. Mikaeloff, B. Fontaine, D. Seilhean, J. Cabane // Acta Neurol Scand.- 2003.- P. 193−200.
- Dove D.J. Chorea associated with oral contraceptive therapy Text. / D.J. Dove // Am J Obstet.Gynecol.- 15−7-1980.- Vol.137, № 6.-P.740−742.
- Diagnostic value of magnetic resonance tomography in disseminated encephalomyelitis. [Text] / W. Weihe, W. Gowin, C. Appel, G. Mariss, D. Nieber //Nervenarzt.- 1987.- P. 158−164.
- Divry-Van Bogaert cortico-meningeal angiomatosis and Sneddon’s syndrome. Nosological study. Apropos of 4 cases. [Text] / E. Ellie, J. Julien, P. Henry, C. Vital, X. Ferrer // Rev. Neurol (Paris).- 1987.- P.798−805.
- Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients Text. / H.H. Liou, C.R. Wang, C.J. Chen, R.C. Chen, C.Y. Chuang, I.P. Chiang, M.C. Tsai // Lupus.- 1996.- P.307−312.
- Etiological studies on 17 cases of retinal artery occlusion and 16 cases of amaurosis fugax. [Text] / Y. Hashimoto, T. Terasaki, Y. Hara, N. Furuyoshi, M. Uchino // Rinsho Shinkeigaku.- 1998.- P.219−223.
- Extent of cerebral white matter lesions is related to changes of circadian blood pressure rhythmicityText. / D. Sander, K. Winbeck, J. Klingelhofer,
- B. Conrad // Archives of Neurology.- 2000.- P. 1302−1307.
- Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children Text. / G. Kenet, S. Sadetzki, H. Murad, U. Martinowitz, N. Rosenberg, S. Gitel, G. Rechavi, A. Inbal // Stroke.- 2000.-P.1283−1288.
- Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions Text. / S. Bastianello, A. Bozzao, A. Paolillo, E. Giugni,
- C. Gasperini, T. Koudriavtseva, E. Millefiorini, M.A. Horsfield, C. Colonnese, D. Toni, M. Fiorelli, C. Pozzilli, L. Bozzao // AJNR Am J Neuroradiol.- 1997.- P.699−704.
- Feldmann E. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options Text. / E. Feldmann, S.R. Levine // Ann.Neurol.- 1995.- Vol.37 Suppl 1, βS114-S130.
- Fernando S.J. An attack of chorea complicating oral contraceptive therapy Text. / S.J. Fernando // Practitioner.- 1966.- Vol.197, № 178.- P.210−211.
- Fisher C.M. Lacunar strokes and infarcts: a review Text. / C.M. Fisher // Neurology.- 1982.- Vol.32, № 8.- P.871−876.
- Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions Text. / M.A. Kuharik, M.K. Edwards, M.R. Farlow, G.J. Becker, B.
- Azzarelli, E.C. Klatte, G.T. Augustyn, R.G. Dreesen // AJNR Am J Neuroradiol.- 1988.- P.643−648.
- Geller T.J. Focal MRI findings in early SSPE Text. / T.J. Geller, B.A. Vern, M. Sarwar // Pediatr.Neurol.- 1987.- Vol.3, № 5.- P.310−312.
- Gentry L.R. MR imaging of head trauma: review of the distribution and radiopathologic features of traumatic lesions Text. / L.R. Gentry, J.C. Godersky, B. Thompson // AJR Am J Roentgenol.- 1988.- Vol.150, № 3.- P.663−672.
- Giorgi D. The clinico-ophthalmological spectrum of antiphospholipid syndrome Text. / D. Giorgi, C.B. Gabrieli, L. Bonomo // Ocul.Immunol.Inflamm.- 1998.- Vol.6, № 4.- P.269−273.
- Green L. Sudden sensorineural hearing loss as a first manifestation of systemic lupus erythematosus: association with anticardiolipin antibodies Text. / L. Green, E.B. Miller // Clin Rheumatol.- 2001.- Vol.20, № 3.-P.220−222.
- Greenan T.J. Cerebral vasculitis: MR imaging and angiographic correlation Text. / T.J. Greenan, R.I. Grossman, H.I. Goldberg // Radiology.- 1992,-Vol.182, № 1.- P.65−72.
- Grob J.J. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature Text. / J J. Grob, J J. Bonerandi // J Am.Acad.Dermatol.- 1986.- Vol.15, № 2 Pt 1.-P.211−219.
- Hagg S. Antipsychotic-induced venous thromboembolism: a review of the evidence Text. / S. Hagg, O. Spigset // CNS.Drugs.- 2002.- Vol.16, № 11.-P.765−776.
- Halperin J.J. Nervous system manifestations of Lyme disease 3Text. / J.J. Halperin // Rheum Dis Clin North Am.- 1989.- Vol.15, № 4.-P.635−647.
- Hanly J.G. Evaluation of patients with CNS involvement in SLE Text. / J.G. Hanly // Baillieres Clin Rheumatol.- 1998.- Vol.12, № 3.-P.415−431.
- Hanly J.G. ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables 4Text. / J.G. Hanly// Lupus.- 2004.- Vol.13, № 11.- P.861−864.
- Hanly J.G. Brain pathology in systemic lupus erythematosus Text. / J.G. Hanly, N.M. Walsh, V. Sangalang // J Rheumatol.- 1992.-Vol. 19, № 5.- P.732−741.
- High association of anticardiolipin antibodies with psychosis Text. / M. Schwartz, M. Rochas, B. Weiler, A. Sheinkman, I. Tal, D. Golan, N. Toubi, I. Eldar, B. Sharf, D. Attias // J Clin Psychiatry.- 1998.-P.20−23.
- Hughes G.R.V. The anticardiolipin syndrome Text. / Hughes G.R.V., Gharavi A.E. // Rheumatology.- 1986.- Vol.13, № 486.
- Hughes G.R. Migraine, memory loss, and «multiple sclerosis «. Neurological features of the antiphospholipid (Hughes') syndrome Text. / G.R. Hughes // Postgrad. Med J.- 2003.- Vol.79, № 928.- P.81−83.
- Hughes G.R. Antiphospholipid syndrome: linking many specialties Text. / G.R. Hughes, R.A. Asherson, M.A. Khamashta // Ann Rheum Dis.- 1989.-Vol.48, № 5.- P.355−356.
- Hughson M.D. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome Text. / M.D. Hughson, G.A. McCarty, R.A. Brumback // Hum.Pathol.- 1995.- Vol.26, № 7.- P.716−724.
- Hurst R.W. Fetal intracranial hemorrhage and periventricular leukomalacia: complications of twin-twin transfusion Text. / R.W. Hurst, P.L. Abbitt // AJNR Am J Neuroradiol.- 1989.- Vol.10, № 5 Suppl.- P. S62-S63.
- Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts Text. / H. Mast, J.L. Thompson, S.H. Lee, J.P. Mohr, R.L. Sacco // Stroke.- 1995.- P.30−33.
- Idiopathic intracranial hypertension and anticardiolipin antibodies Text. / A. Kesler, M.H. Ellis, T. Reshef, E. Kott, N. Gadoth // Journal of Neurology, Neurosurgery, and Psychiatry.- 2000, — P.379−380.
- Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome Text. / G. Medina, D. Casaos, L.J. Jara, O. Vera-Lastra, M. Fuentes, L. Barile, M. Salas // Ann. Rheum Dis.- 2003.- P.607−610.
- Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts Text. / F. Pasquier, D. Leys, J.G. Weerts, F. Mounier-Vehier, F. Barkhof, P. Scheltens // Eur.Neurol.- 1996.-P.268−272.
- Intracardiac thrombosis and mitral prosthesis dysfunction in systemic lupus erythematosus. A case report Text. / A.N. da Silva, L.D. Ferreira, C.G. Monaco, C.E. Silva, M.A. Gil, L.B. Peixoto, J. Ortiz // Rev.Port.Cardiol.-2003.- P.213−219.
- Intracranial hypertension in a patient with pseudomigraine with pleocytosis. [Text] / I. Pericot, M. Tintore, X. Montalban, R. Rovira, A. Codina // Neurologia.- 2000.- P. 143−145.
- Inzelberg R. Lupus anticoagulant and late onset seizures Text. / R. Inzelberg, A.D. Korczyn // Acta Neurol Scand.- 1989.- Vol.79, № 2.- P. l 14 118.
- Johnson R.T. The neurological manifestations of systemic lupus erythematosus Text. / R.T. Johnson, E.P. Richardson // Medicine (Baltimore).- 1968.- Vol.47, № 4.- P.337−369.
- Joseph R.E. Antiphospholipid antibody syndrome and renal disease Text. / R.E. Joseph, J. Radhakrishnan, G.B. Appel // Curr.Opin.Nephrol.Hypertens.-2001.- Vol.10, № 2.- P. 175−181 .
- Kajs-Wyllie M. Lupus cerebritis: a case study Text. / M. Kajs-Wyllie // J Neurosci.Nurs.- 2002.- Vol.34, № 4.- P. 176−183.
- Kaiman B. Spectrum and classification of inflammatory demyelinating diseases of the central nervous system Text. / B. Kaiman, F.D. Lublin // Curr. Neurol Neurosci.Rep.- 2001.- Vol.1, № 3.- P.249−256.
- Karpiak S.E. Antiserum to brain gangliosides produces recurrent epileptiform activity Text. / S.E. Karpiak, L. Graf, M.M. Rapport // Science.- 1976.- Vol.194, № 4266.- P.735−737.
- Katzav A. CNS dysfunction in the antiphospholipid syndrome Text. / A. Katzav, J. Chapman, Y. Shoenfeld // Lupus.- 2003.- Vol.12, № 12.- P.903−907.
- Khamashta M.A. Antiphospholipid antibodies and antiphospholipid syndrome Text. / M.A. Khamashta, G.R. Hughes // Curr.Opin.Rheumatol.-1995.- Vol.7, № 5.- P.389−394.
- Khubchandani R.P. Antiphospholipid antibody syndrome as a cause of Budd-Chiari syndrome Text. / R.P. Khubchandani, S. D’Souza // Indian Pediatr.- 2003.- Vol.40, № 9.- P.907−908.
- Kirkpatrick J.B. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis Text. / J.B. Kirkpatrick, L.A. Hayman // Radiology.- 1987.- Vol.162, № 2.-P.509−511.
- Klein R. Nodular regenerative hyperplasia (NRH) of the liver—a manifestation of 'organ-specific antiphospholipid syndrome'? Text. / R. Klein, S. Goller, L. Bianchi // Immunobiology.- 2003.- Vol.207, № 1.- P.51−57.
- Knepper L.E. Cerebrovascular disease in women Text. / L.E. Knepper, M.J. Giuliani // Cardiology.- 1995.- Vol.86, № 4.- P.339−348.
- Kobayashi S. Systemic lupus erythematosus with sensorineural hearing loss and improvement after plasmapheresis using the double filtration method Text. / S. Kobayashi, N. Fujishiro, K. Sugiyama // Intern.Med.- 1992.-Vol.31, № 6.- P.778−781.
- Koeppen S. Progressive multifocal leukoencephalopathy: neurological findings and evaluation of magnetic resonance imaging and computed tomography
- Text. / S. Koeppen, H.J. Lehmann // Neurosurg Rev.- 1987.- Vol.10, № 2.-P. 127−132.
- Kwon S.U. Vertebrobasilar artery territory infarction as an initial manifestation of systemic lupus erythematosus 2Text. / S.U. Kwon, J.Y. Koh, J.S. Kim // Clin Neurol Neurosurg.- 1999.-Vol.101, № 1.- P.62−67.
- Kworth-Young C.G. Epilepsy: an early symptom of systemic lupus erythematosus Text. / C.G. kworth-Young, G.R. Hughes // Journal of Neurology, Neurosurgery, and Psychiatry.- 1985.- Vol.48, № 2.- P. 185−195
- Lack of association between antiphospholipid antibodies and migraine in children Text. / A. Verrotti, F. Cieri, P. Pelliccia, G. Morgese, F. Chiarelli // Int. J Clin Lab Res.- 2000.- P. 109−111.
- Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus Text. / J. Montalban, R. Cervera, J. Font, J. Ordi, J. Vianna, H.J. Haga, M. Tintore, M.A. Khamashta, G.R. Hughes // Neurology.- 1992.- P.681−682.
- Lack of difference in brain hyperintensities between patients with early Alzheimer’s disease and control subjects lText. / T. Erkinjuntti, F. Gao, D.H. Lee, M. Eliasziw, H. Merskey, V.C. Hachinski //Archives of Neurology.- 1994.- P.260−268.
- Lancman M.E. Magnetic resonance imaging findings in lupus ataxia 3Text. / M.E. Lancman, C. Pomeraniec, J. Norscini // Acta Neurol Scand.-1992.- Vol.86, № 4.- P.425−426.
- Large Virchow-Robin spaces: MR-clinical correlation Text. / L.A. Heier, C.J. Bauer, L. Schwartz, R.D. Zimmerman, S. Morgello, M.D. Deck // AJNR Am J Neuroradiol.- 1989.- P.929−936.
- Lauterbur P.C. Image formation by induced local interactions. Examples employing nuclear magnetic resonance (1973). Text. / P.C. Lauterbur // Clin Orthop.- 1989.- Vol.244.- P.3−6.
- Lee D.M. Transverse myelitis in a patient with primary antiphospholipid syndrome Text. / D.M. Lee, H.S. Jeon, W.H. Yoo // Yonsei Med J.- 30−42 003.- Vol.44, № 2.- P.323−327.
- Leker R.R. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension Text. / R.R. Leker, I. Steiner // Archives of Neurology.- 1998.- Vol.55, № 6.- P.817−820.
- Levine J.S. The antiphospholipid syndrome Text. / J.S. Levine, D.W. Branch, J. Rauch //N.Engl.J Med.- 2002.- Vol.346, № 10.- P.752−763.
- Levine S.R. Neurological aspects of antiphospholipid antibody syndrome Text. / S.R. Levine, R.L. Brey // Lupus.- 1996.- Vol.5, № 5.- P.347−353.
- Li E.K. Cerebral venous thrombosis in systemic lupus erythematosus Text. / E.K. Li, R.L. Kay, M.G. Cohen // Stroke.- 1991.- Vol.22, № 2.-P.281−283.
- Liem M.D. MRI and angiographic diagnosis of lupus cerebral vasculitis Text. / M.D. Liem, D.J. Gzesh, A.E. Flanders // Neuroradiology.- 1996.-Vol.38, № 2.- P.134−136.
- Lillicrap M.S. Symptomatic antiphospholipid syndrome induced by chlorpromazine Text. / M.S. Lillicrap, G. Wright, A.C. Jones // Br J Rheumatol.- 1998.- Vol.37, № 3.- P.346−347.
- Lim J.K. Lupus cerebritis and steroid psychosis in mixed connective tissue disorder Text. / J.K. Lim, M.L. Kraus, S.S. Giles // Yale J Biol Med.-2004.- Vol.77, № 3.- P.63−69.
- Lithander A. Unsuspected cases of positive Wassermann reaction. [Text] / Lithander A. //Nord Med.- 19−5-1955.- Vol.53, № 20.- P. l-3.
- Location of the corticospinal tract in the internal capsule at MR imaging Text. / A. Yagishita, I. Nakano, M. Oda, A. Hirano // Radiology.- 1994.-P.455−460.
- Localized cutaneous necrosis associated with the antiphospholipid syndrome Text. / M.P. Sharkey, I.I. Daryanani, M.B. Gillett, S.K. Jones // Australas. J Dermatol.- 2002.- P.218−220.
- Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases Text. / J.F. Tellez-Zenteno, J.M. Remes-Troche, R.O. Negrete-Pulido, L. vila-Maldonado // Lupus.- 2001.- P.851−856.
- Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort Text. / C. Dufouil, A. de Kersaint-Gilly, V. Besancon, C. Levy, E. Auffray, L. Brunnereau, A. Alperovitch, C. Tzourio // Neurology.-10−4-2001.- P.921−926.
- Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies Text. / E.N. Harris, A.E. Gharavi, C.G. kworth-Young, B.M. Patel, G. Derne, G.R. Hughes //Ann.Rheum Dis.- 1985.- P.281−283.
- Lupus anticoagulant, antiphospholipid antibodies and migraine Text. / M.J. Hogan, D.G. Brunet, P.M. Ford, D. Lillicrap // Can. J Neurol Sei.- 1988.- P.420−425.
- Lupus anticoagulant induced by the combination of valproate and lamotrigine Text. / A. Echaniz-Laguna, A. Thiriaux, I. Ruolt-OIivesi, C. Marescaux, E. Hirsch // Epilepsia.- 1999.- P. 1661−1663.
- Lyme neuroborreliosis: central nervous system manifestations 5Text. / J.J. Halperin, B.J. Luft, A.K. Anand, C.T. Roque, O. Alvarez, D.J. Volkman, R.J. Dattwyler//Neurology.- 1989.- P.753−759.
- Magnetic resonance and CT imaging correlated with clinical status in SSPE Text. / G.B. Lum, J.P. Williams, P.R. Dyken, B.C. Machen, P.M. Dotson, M.D. Harpen, N. McLeod // Pediatr.Neurol.- 1986.- P.75−79.
- Magnetic resonance imaging in central nervous system sarcoidosis 1 Text. / D.H. Miller, B.E. Kendall, S. Barter, G. Johnson, D.G. MacManus, S.J. Logsdail, I.E. Ormerod, W.I. McDonald // Neurology.- 1988.- P.378−383.
- Magnetic resonance imaging in childhood disseminated encephalomyelitis Text. / Z. Perdue, J.F. Bale, Jr., V.D. Dunn, W.E. Bell // Pediatr.Neurol.-1985.- P.370−374.
- Magnetic resonance imaging: serial observations in multiple sclerosis Text. / M.A. Johnson, D.K. Li, D.J. Bryant, J.A. Payne // AJNR Am J Neuroradiol.- 1984.-P.495−499.
- Magnetic resonance imaging using FLAIR pulse sequence in white matter diseases Text. / A. Tourbah, R. Deschamps, J.L. Stievenart, A. Lopez, M.T. Iba-Zizen, O. Lyon-Caen, E.A. Cabanis // J Neuroradiol.- 1996.- P.217−222.
- Majewska Z. Positive Wassermann reaction in tuberculous meningitis. [Text] / Majewska Z. // Pol.Tyg.Lek.(Wars.).- 1954.- Vol.9, № 24.- P.740−743.
- Mansfield P. Line scan proton spin imaging in biological structures by NMR Text. / P. Mansfield, A.A. Maudsley // Phys. Med Biol.- 1976.- Vol.21, № 5.- P.847−852.
- Mansfield P. Medical imaging by NMR Text. / P. Mansfield, A.A. Maudsley//Br J Radiol.- 1977.- Vol.50, № 591.- P. 188−194.
- Marcus D.A. Central nervous system abnormalities in migraine Text. / D.A. Marcus 11 Expert.Opin.Pharmacother.- 2003.- Vol.4, № 10.-P.1709−1715.
- Masakatsu S. Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis Text. / Masakatsu S, Ayako N // Mod Rheumatol.-2001.- Vol.11, № 159−161.
- Mechanisms in lacunar infarction Text. / D.R. Horowitz, S. Tuhrim, J.M. Weinberger, S.H. Rudolph // Stroke.- 1992.- P.325−327.
- Migraine and anti-phospholipid antibodies Text. / A. Shuaib, L. Barklay, M.A. Lee, O. Suchowersky // Headache.- 1989, — P.42−45.
- Migraine in Hughes syndrome—heparin as a therapeutic trial? Text. / M.J. Cuadrado, M.A. Khamashta, D. D’Cruz, G.R. Hughes // QJM.-2001.- P. l 14−115.
- Migrainous stroke and the antiphospholipid antibodies Text. / M. Silvestrini, M. Matteis, E. Troisi, L.M. Cupini, G. Zaccari, G. Bernardi // Eur.Neurol.- 1994.- P.316−319.
- Milanov I. Antiphospholipid syndrome and dystonia-parkinsonism. A case report Text. / I. Milanov, D. Bogdanova // Parkinsonism. Relat Disord.-2001.-Vol.7, № 2.- P.139−141.
- Miserocchi E. Ocular features associated with anticardiolipin antibodies: a descriptive study Text. / E. Miserocchi, S. Baltatzis, C.S. Foster // Am J Ophthalmol.- 2001.- Vol.131, № 4.- P.451−456.
- Mitsias P. Large cerebral vessel occlusive disease in systemic lupus erythematosus Text. / P. Mitsias, S.R. Levine // Neurology.- 1994.- Vol.44, № 3 Pt 1.- P.385−393.
- Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system Text. / M. Kent, F. Alvarez, E. Vogt, R. Fyffe, A.K. Ng, N. Rote//J Rheumatol.- 1997.- P. 1725−1733.
- Mohr J.P. Lacunes Text. / J.P. Mohr // Stroke.- 1982.- Vol.13, № 1.- P.3−11.
- Mohr J.P. Lacunes Text. / J.P. Mohr // Neurol Clin.- 1983.- Vol.1, № 1.-P.201−221.
- Mokri B. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies Text. / B. Mokri, C.R. Jack, Jr., G.W. Petty // Stroke.- 1993.- Vol.24, № 3.- P.469−472.
- MR and CT evaluation of intracranial sarcoidosis Text. / W.S. Hayes, J.L. Sherman, B.J. Stern, C.M. Citrin, P.D. Pulaski // AJR Am J Roentgenol.- 1987.- P. 1043−1049.
- MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences Text. / C.B. De, J.V. Hajnal, P. Gatehouse, D.B. Longmore, S.J. White, A. Oatridge, J.M. Pennock, I.R. Young, G.M. Bydder // AJNR Am J Neuroradiol.- 1992.- P. 1555−1564.
- Muir K.W. Anticardiolipin antibodies and cerebral infarction Text. / K.W. Muir, I.B. Squire, W. Alwan // Journal of Neurology, Neurosurgery, and Psychiatry.- 1994.- Vol.57, № 2.- P.253−254.
- Multi-infarct dementia associated with antiphospholipid antibodies. Presentation of 2 cases. [Text] / J. Montalban, J. Fernandez, A. Arderiu, J. Ordi, M. Vilardell, A. Codina, M. Khamashta // Med Clin (Bare.).- 1989.-P.424−426.
- Multiple sclerosis lesion quantification using fuzzy-connectedness principles Text. / J.K. Udupa, L. Wei, S. Samarasekera, Y. Miki, M.A. van Buchem, R.I. Grossman // IEEE Trans. Med Imaging.- 1997.- P.598−609.
- Myocardial infarction and antiphospholipid antibodies in SLE and related disorders Text. / R.A. Asherson, M.A. Khamashta, E. Baguley, C.M. Oakley, N.R. Rowell, G.R. Hughes // Q. J Med.- 1989.- P. l 103−1115.
- Nagaraja D. Anticardiolipin antibodies in ischemic stroke in the young: Indian experience Text. / D. Nagaraja, R. Christopher, T. Manjari // J Neurol Sei.- 1997.- Vol.150, № 2.- P.137−142.
- Neuropsychological deficits associated with antiphospholipid antibodies Text. / M.W. Jacobson, L.J. Rapport, P.A. Keenan, R.D. Coleman, G.E. Tietjen H J Clin Exp Neuropsychol.- 1999.- P.251−264.
- Neurological and psychiatric symptoms in patients with systemic lupus erythematosus. [Text] / A. Kuczynska-Zardzevvialy, W. Palasik, A. Jedryka-Goral, A. Czlonkowska // Neurol Neurochir.Pol.- 2001.- P.781−792.
- Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features Text. / A.M. Chancellor, R.E. Cull, D.C. Kilpatrick, C.P. Warlow // J Neurol.- 1991.- P.401−407.
- Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood Text. / L. Angelini, F. Zibordi, G. Zorzi, N. Nardocci, R. Caporali, A. Ravelli, A. Martini // Neuropediatrics.- 1996.-P.149−153.
- Neurological, electrophysiological and MRI abnormalities in infants with extensive cystic leukomalacia Text. / L.S. de Vries, J.A. Connell, L.M. Dubowitz, R.C. Oozeer, V. Dubowitz, J.M. Pennock // Neuropediatrics.-1987.- P.61−66.
- Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies Text. /M. Golstein, O. Meyer, P. Bourgeois, E. Palazzo, P. Nicaise, C. Labarre, M.F. Kahn // Clin Exp Rheumatol.- 1993.-P.373−379.
- Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus Text. / A. Sabet, W.L. Sibbitt, Jr., C.A. Stidley, J. Danska, W.M. Brooks // Stroke.- 1998.- P.2254−2260.
- Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event Text. / E.M. Westerman, J.M. Miles, M. Backonja, W.R. Sundstrom // Arthritis Rheum.- 1992.- P. 1038−1041.
- Neuropsychological deficit profiles in systemic lupus erythematosus Text. / R.L. Skeel, B. Johnstone, D.T. Yangco, Jr., S.E. Walker, G.R. Komatireddy // Appl.Neuropsychol.- 2000.- P.96−101.
- Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies Text. / J. Chapman, J.H. Rand, R.L. Brey, S.R. Levine, I. Blatt, M.A. Khamashta, Y. Shoenfeld // Lupus.- 2003.- P.514−517.
- Norris J.W. Silent stroke and carotid stenosis Text. / J.W. Norris, C.Z. Zhu // Stroke.- 1992.- Vol.23, № 4.- P.483−485.
- Obermoser G. Sneddon’s syndrome is a distinct entity from APS / G. Obermoser, G. Margreiter, M. Abenthung, N. Sepp // International 10th congress on APA: the materials. Innsbruck, 2002. — C. 33 — 34
- Ocular symptoms in association with antiphospholipid antibodies Text. / B. Leo-Kottler, R. Klein, P.A. Berg, E. Zrenner // Graefes Arch Clin Exp Ophthalmol.- 1998.- P.658−668.
- Oksanen V. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis Text. / V. Oksanen // Sarcoidosis.- 1987.- Vol.4, № 2.-P.105−110.
- Okun M.S. Antiphospholipid- associated recurrent chorea and ballism in a child with cerebral palsy Text. / M.S. Okun, R.R. Jummani, P.R. Carney // Pediatr.Neurol.- 2000.- Vol.23, № 1.- P.62−63.
- Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients Text. / N.M. Shah, M.A. Khamashta, T. Atsumi, G.R. Hughes // Lupus.- 1998.- P.3−6.
- Pangborn MC. A new serologically active phospholipid from beef heart Text. / Pangborn MC. // Proc Soc Exp Biol Med.- 1941.- Vol.48, № 484 486.
- Partial seizures associated with antiphospholipid antibodies in childhood Text. / L. Angelini, T. Granata, F. Zibordi, S. Binelli, G. Zorzi, C. Besana // Neuropediatrics.- 1998.- P.249−253.
- Patients with antiphospholipid antibodies: CT and MR findings of the brain Text. / J.M. Provenzale, D.P. Barboriak, N.B. Allen, T.L. Ortel // AJR Am. J Roentgenol.- 1996.- P. 1573−1578.
- Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus Text. / B.I. Glanz, D. Slonim, M.B. Urovvitz, D.D. Gladman, J. Gough, A. MacKinnon // Neuropsychiatry Neuropsychol.Behav.Neurol.-1997.- P.232−238.
- Peng T.C. Maternal disease and injury in pregnancy Text. / T. C, Peng // Curr.Opin.Obstet.Gynecol.- 1993.- Vol.5, № 1.- P.3−9.
- Periventricular hyperintensity on magnetic resonance imaging correlated with brain ageing and atrophy Text. / K. Meguro, T. Yamaguchi, T. Hishinuma, H. Miyazawa, S. Ono, K. Yamada, T. Matsuzawa // Neuroradiology.- 1993.- P. 125−129.
- Phosphatidylserine-dependent antiprothrombin antibodies are not useful markers for high-risk women with recurrent miscarriages Text. / M. Sugiura-Ogasawara, T. Atsumi, Y. Ozaki, T. Koike, K. Suzumori // Fertil.Steril.- 2004.- P. 1440−1442.
- Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant Text. / J. Matsuda, N. Saitoh, M. Gotoh, K. Kawasugi, K. Gohchi, M. Tsukamoto // Br J Rheumatol.- 1996.- P.589−591.
- Possible induction of systemic lupus erythematosus by zonisamide Text. / K. Mutoh, Y. Hidaka, Y. Hirose, M. Kimura // Pediatr.Neurol.- 2001.-P.340−343.
- Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension Text. / J. Sussman, M. Leach, M. Greaves, R. Malia, G.A. Vies-Jones // Journal of Neurology, Neurosurgery, and Psychiatry.- 1997.-P.229−233.
- Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy Text. / D. Verrot, M. San-Marco, C. Dravet, P. Genton, P. Disdier, G. Bolla, J.R. Harle, L. Reynaud, P.J. Weiller // Am J Med.- 1997.- P.33−37.
- Primary angiitis of the central nervous system: serial MRI of brain and spinal cord Text. / A. Campi, G. Benndorf, M. Filippi, P. Reganati, V. Martinelli, M.R. Terreni //Neuroradiology.- 2001.- P.599−607.
- Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy Text. / B. Wiechens, J.O. Schroder, B. Potzsch, R. Rochels // Am J Ophthalmol.- 1997.- P.848−850.
- Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients Text. / J.H. Kim, C.G. Choi, S.J. Choi, H.K. Lee, D.C. Suh // Korean J Radiol.- 2000.- P.5−10.
- Primary antiphospholipid syndrome: functional outcome after 10 years Text. / D. Erkan, Y. Yazici, R. Sobel, M.D. Lockshin // J Rheumatol.-2000.- P.2817−2821.
- Primary antiphospholipid syndrome: clinical and biological study of 36 cases. [Text] / J. Vivancos, A. Lopez-Soto, J. Font, J. Balasch, R. Cervera, J.C. Reverter, F. Carmona, M. Ingelmo // Med Clin (Bare.).- 23−4-1994.-P.561−565.
- Primary antiphospholipid syndrome (PAPS) and isolated partial seizures in adolescence. A case report Text. / R. Spreafico, S. Binelli, M.G. Bruzzone, D. Croci, V. Rumi, L. Angelini // Ital. J Neurol Sei.- 1994.- P.297−301.
- Primary antiphospholipid syndrome presenting as pseudobulbar palsy in a young male Text. / M.A. Aleem, K. Govindaraj, V.J. Senthil, V. Kanagaraj, V. Jayapal // J Assoc. Physicians India.- 2001.- P.1036−1038.
- Primary biliary cirrhosis associated with antiphospholipid syndrome Text. / M. Hoffman, M. Burke, M. Fried, D. Turner, Y. Yosipov, I. Yust // Isr. J Med Sei.- 1997.- P.681−686.
- Progressive encephalopathy in antiphospholipid antibody syndrome. [Text] / M. Ceccaldi, J.R. Harle, I. Sangla, M. Poncet // Presse Med.- 1993.- № 9.-P.1313−1316.
- Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon Text. / K. Tashiro, S. Doi, F. Moriwaka, Y. Maruo, M. Nomura // J Neurol.- 1987.-P.427−429.
- Proton magnetic resonance imaging in ischemic cerebrovascular disease Text. / E.D. Saigado, M. Weinstein, A.J. Furlan, M.T. Modic, G.J. Beck, M. Estes, I. Awad, J.R. Little // Ann Neurol.- 1986.- P.502−507.
- Provenzale J.M. Brain infarction in young adults: etiology and imaging findings Text. / J.M. Provenzale, D.P. Barboriak // AJR Am. J Roentgenol.-1997.- Vol.169, № 4.- P. l 161−1168.
- Purvin V. MRI and cerebral venous thrombosis Text. / V. Purvin, D.W. Dunn, M. Edwards // Comput.Radiol.- 1987.-Vol.ll, № 2.- P.75−79.
- Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment Text. / K. Wada, N. Yamada, H. Suzuki, Y. Lee, S. Kuroda // J Clin Psychiatry.- 2000.- P.261−267.
- Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions Text. / D.M. Jacobson, J.H. Lewis, F.A. Bontempo, J.A. Spero, M.V. Ragni, O.M. Reinmuth // Stroke.-1986.- P.98−102.
- Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome Text. / S.R. Levine, R.L. Brey, K.L. Sawaya, L. Salowich-Palm, J. Kokkinos, B. Kostrzema, M. Perry, S. Havstad, J. Carey // Ann Neurol.-1995.- P. l 19−124.
- Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study Text. / O. Heinzlef, N. Abuaf, A. Cohen, P. Amarenco // J Neurol.- 2001.- P.373−379.
- Rice H.M. The incidence and demonstration of biologic reactions in routine Wassermann tests Text. / Rice H.M. // Br J Vener Dis.- 1952.- Vol.28(4), № 197−200.
- Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study Text. / G.E. Tietjen, M. Day, L. Norris, S. Aurora, A. Halvorsen, L.R. Schultz, S.R. Levine // Neurology.- 1998.- P.1433−1440.
- Roman G.C. On the history of lacunes, etat crible, and the white matter lesions of vascular dementia Text. / G.C. Roman // Cerebrovasc Dis.-2002.- Vol.13 Suppl 2, № 1.- P.6−10.
- Ropper A.H. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms Text. / A.H. Ropper, D.C. Poskanzer // Ann Neurol.- 1978.- Vol.4, № 1.-P.51−59.
- Rosenstein E.D. Isolated, pupil-sparing third nerve palsy as initial manifestation of systemic lupus erythematosus Text. / E.D. Rosenstein, J. Sobelman, N. Kramer // J Clin Neuroophthalmol.- 1989.- Vol.9, № 4.- P.285−288.
- Saida T. Magnetic resonance imaging in multiple sclerosis. [Text] / T. Saida // Rinsho Shinkeigaku.- 1999.- Vol.39, № 1.- P. 114−115.
- Salvati C.A. Cerebral vein thrombosis shown by MRI Text. / C.A. Salvati // Headache.- 1990.- Vol.30, № 10.- P.650−651.
- Sarwar M. Radiologic techniques in the diagnosis of CNS infections Text. / M. Sarwar, G. Falkoff, M. Naseem // Neurol Clin.- 1986.- Vol.4, № 1.- P.41−68.
- Sastre-Garriga J. APS and the brain Text. / J. Sastre-Garriga, X. Montalban // Lupus.- 2003.- Vol.12, № 12.- P.877−882.
- Scott T.F. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging Text. / T.F. Scott, D. Hess, J. Brillman // Arch Intern.Med.- 1994.- Vol.154, № 8.-P.917−920.
- Sepp N. Sneddon’s syndrome-an inflammatory disorder of small arteries followed by smooth muscle proliferation: immunhistochemical and ultrastructural evidence Text. /N. Sepp, B. Zelger, G. Schuler// Am J Surg Pathol.- 1995.- Vol.19, № 448−453.
- Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis Text. / D.H. Miller, P. Rudge, G. Johnson, B.E. Kendall, D.G. MacManus, I.F. Moseley, D. Barnes, W.I. McDonald // Brain.- 1988.-P.927−939.
- Significance of magnetic resonance imaging in acute head injury Text. / H. Yokota, A. Kurokawa, T. Otsuka, S. Kobayashi, S. Nakazawa // J Trauma.- 1991.- P.351−357.
- Silvestrini M. Migrainous stroke and antiphospholipid antibodies: are they pathogenetically linked? Text. / M. Silvestrini // Eur.Neurol.- 1996.-Vol.36, № 2.- P.114
- Simple partial status epilepticus and antiglycolipid IgM antibodies: possible epilepsy of autoimmune origin Text. / B. Guillon, F.E. de, J.R. Feve, J. Honnorat, C. Caudie, B. Nogues, P. Moreau // Archives of Neurology.-1997.- P. l 194−1196.
- Smith R.R. Leuko-araiosis: description and clinical correlates Text. / R.R. Smith, H.C. Hendrie // Compr.Ther.- 1992.- Vol.18, № 1.- P.7−16.
- Sneddon I. Cerebro-vascular lesions and livedo reticularis Text. / Sneddon I. // Br J Dermatol.- 1965.- Vol.77, № 180−185.
- Sneddon’s syndrome: an antiphospholipid antibody syndrome? Text. / L.S.A.G.W.K. Levine SR//Neurology.- 1998.-P.798−800.
- Sneddon syndrome and antiphospholipid antibodies. [Text] / M.A. Khamashta, R.A. Asherson, A. Gil, G.R. Hughes // Med Clin (Barc.).-1988.- P.514−515.
- Sneddon syndrome: vasculitis or thrombotic disorder?. [Text] / S.G. Zipper, S. Lambert, W.R. Seemann, U. Baer, K. Schlisske // Med.Klin.(Munich).-2000.- P.158−162.
- Sneddon’s syndrome vasculopathy with antiphospholipid antibodies in a child. [Text] / C. Villaizan, M.J. Ferrada, I. Legarda, J. Iriarte, J. Narbona, J.M. Martinez-Lage //Neurologia.- 1995.- P.41−45.
- Stojanovich L. Antiphospholipid antibodies in patients with neuropsychiatric systemic lupus / L. Stojanovich, I. Elezovich, R. Stojanovich, V. Mirchetich, V. Kostich // International 10th congress on APA: the materials. Innsbruck, 2002.-C. 23
- Stroke in systemic lupus erythematosus Text. / Y. Kitagawa, F. Gotoh, A. Koto, H. Okayasu // Stroke.- 1990.- P.1533−1539.
- Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 Text. / R.L. Brey, J. Chapman, S.R. Levine, G. Ruiz-Irastorza, R.H. Derksen, M. Khamashta, Y. Shoenfeld // Lupus.- 2003.- P.508−513.
- Stroke in the course of cerebral arteritis. [Text] / M. Krzesniak-Bohdan, M. Swierkocka-Miastkowska, Z. Banecka-Majkutewicz, L. Dobrzynska//Neurol Neurochir.Pol.- 1999.- P.129−132.
- Sudden sensorineural hearing loss associated with anticardiolipin antibody. [Text] / K. Hisashi, S. Komune, S. Komiyama, K. Nakamura // Nippon Jibiinkoka Gakkai Kaiho.- 1996.- P. 1157−1161.
- Suwalska A. Psychiatric complications of glucocorticoid treatment. [Text] / A. Suwalska, D. Lojko, J. Rybakovvski // Psychiatr.Pol.- 2002.-Vol.36, № 2.- P.271−280.
- Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study Text. / A. Tourbah, A. Clapin, O. Gout, B. Fontaine, R. Liblau, F.
- Batteux, J.L. Stievenart, B. Weill, C. Lubetzki, O. Lyon-Caen // Archives of Neurology.- 1998.- P.517−521.
- Systemic lupus erythematosus with affection to brainstem: report of three cases. [Text] / A.J. Mimenza-Alvarado, J.F. Tellez-Zenteno, C. Cantu-Brito, G. Garcia-Ramos // Rev.Neurol.- 16−7-2002.- P.128−131.
- Systemic lupus erythematosus with optical neuromyelitis (Devic's syndrome). A case with a 35-year follow-up Text. / J. Margaux, G. Hayem, O. Meyer, M.F. Kahn // Rev.Rhum.Engl.Ed.- 1999.- P.102−105.
- Takeda S. Brain atrophy and cerebral infarction Text. / S. Takeda, T. Matsuzawa, H. Yamaura // Tohoku J Exp Med.- 1984.- Vol.144, № 4.-P.361−367.
- The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus Text. / D. Giorgi, G.C. Balacco, L. Bonomo // Rheumatology (Oxford).- 1999.- P. 191−192.
- The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases Text. / M. Rovaris, M. Inglese, B. Viti, G. Ciboddo, S. Gerevini, R. Capra, M. Filippi // J Neurol.- 2000.-P.29−33.
- The frequency of phospholipid antibodies in an unselected stroke population Text. / L.M. Metz, S. Edworthy, R. Mydlarski, M.J. Fritzler // Can. J Neurol Sei.- 1998.- P.64−69.
- The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging Text. / S.S. Gebarski, T.O. Gabrielsen, S. Gilman, J.E. Knake, J.T. Latack, A.M. Aisen // Ann Neurol.- 1985.- P.469−474.
- The lung in the antiphospholipid syndrome Text. / G. Espinosa, R. Cervera, J. Font, R.A. Asherson // Annals of the Rheumatic Diseases.- 2002.- P. 195 198.
- The natural course of cerebral lesions in Sneddon syndrome Text. / A. Tourbah, J.C. Piette, M.T. Iba-Zizen, O. Lyon-Caen, P. Godeau, C. Frances // Archives of Neurology.- 1−1-1997.- P.53−60.
- The neuroimaging features of the cardiolipin antibody syndrome Text. / K. Weingarten, C. Filippi, D. Barbut, R.D. Zimmerman // Clin.Imaging.- 1997.-P.6−12.
- The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus Text. / H. Ainiala, J. Loukkola, J. Peltola, M. Korpela, A. Hietaharju // Neurology.- 2001.- P.496−500.
- The relationship between brain atrophy and asymptomatic cerebral lesions. [Text] / S. Yamano, N. Sawai, S. Minami, K. Nomura, Y. Yamamoto, R. Fukui, M. Takaoka, K. Dohi //Nippon Ronen Igakkai Zasshi.- 1997.- P.913−919.
- The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus Text. / S.D. Denburg, R.M. Carbotte, J.S. Ginsberg, J.A. Denburg // J Int.Neuropsychol.Soc.- 1997.- P.377−386.
- Thong B.Y. A case of Sjogren’s syndrome or multiple sclerosis? A diagnostic and therapeutic dilemma Text. / B.Y. Thong, N. Venketasubramanian // Rheumatol Int.- 2002.- Vol.22, № 6.- P.256−258.
- Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome Text. / M.D. Hughson, G.A. McCarty, C.M. Sholer, R.A. Brumback // Mod Pathol.- 1993.- P.644−653.
- Thrombus on the tricuspid valve in a patient with primary antiphospholipid syndrome after implantation of an inferior vena cave filter Text. / M. Ebato, H. Kitai, H. Kumakura, Y. Nakamura, N. Shimizu, Y. Takeyama // Circ.J.-2002.- P.425−427.
- Tietjen G.E. Migraine and antiphospholipid antibodies Text. / G.E. Tietjen // Cephalalgia.- 1992.- Vol.12, № 2.- P.69−74.
- Toluene abuse causes diffuse central nervous system white matter changes Text. / N.L. Rosenberg, B.K. Kleinschmidt-DeMasters, K.A. Davis, J.N. Dreisbach, J.T. Hormes, C.M. Filley // Ann Neurol.- 1988.- P.611−614.
- Transient global amnesia and antiphospholipid antibodies Text. / J. Montalban, A. Arboix, H. Staub, J. Barquinero, J. Marti-Vilalta, A. Codina, G.R. Hughes // Clin Exp Rheumatol.- 1989.- P.85−87.
- Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome Text. / D. Giorgi, V. David, A. Afeltra, C.B. Gabrieli // Ocul.Immunol.Inflamm.- 2001.- P.49−57.
- Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies Text. / C. Lavalle, S.
- Pizarro, C. Drenkard, J. Sanchez-Guerrero, D. Alarcon-Segovia // J Rheumatol.- 1990.- P.34−37.
- Transverse myelitis in patients with antiphospholipid antibodies—the importance of early diagnosis and treatment Text. / Y. Sherer, S. Hassin, Y. Shoenfeld, Y. Levy, A. Livneh, A. Ohry, P. Langevitz // Clin Rheumatol.-2002.- P.207−210.
- Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature Text. / B. Kovacs, T.L. Lafferty, L.H. Brent, R.J. DeHoratius // Ann Rheum Dis.- 2000.- P. 120−124.
- Tumiati B. Hearing loss in the Sjogren syndrome Text. / B. Tumiati, P. Casoli, A. Parmeggiani // Ann Intern.Med.- 15−3-1997.- Vol.126, № 6.-P.450−453.
- Unusual cranial and abdominal computed tomographic (CT) scan appearances in a case of systemic lupus erythematosus (SLE) Text. / M. Boulter, A. Brink, C. Mathias, S. Peart, J. Stevens, G. Stewart, R. Unwin // Ann Rheum Dis.- 1987.- P.162−165.
- Utility of simultaneous brain, CSF and hyperintensity quantification in dementia Text. / R.H. Swartz, S.E. Black, A. Feinstein, C. Rockel, G. Sela, F.Q. Gao, C.B. Caldwell, M.J. Bronskill // Psychiatry Res.- 30−11−2002,-P.83−93.
- Value of Turbo-FLAIR sequence in the diagnosis of brain diseases at 0.5 tesla. [Text] / E. Keller, J. Gieseke, D. Kossack, T. Sommer, G. Lutterbey, C. Kuhl, H.H. Schild // Rofo.- 1995.- P.497−504.
- Van H.G. Reversible dementia and chorea in a young woman with the lupus anticoagulant Text. / H.G. Van, F.C. Arnett, M.M. Dimachkie // Neurology.- 1996.- Vol.46, № 6.- P.1599−1603.
- Vascular risk factors linked to multiple lacunar infarcts Text. / S. Spolveri, M.C. Baruffi, C. Cappelletti, F. Semerano, S. Rossi, G. Pracucci, D. Inzitari // Cerebrovasc Dis.- 1998.- P. 152−157.
- Verro P. Cerebrovascular ischemic events with high positive anticardiolipin antibodies Text. / P. Verro, S.R. Levine, G.E. Tietjen // Stroke.- 1998.-Vol.29, № 11.- P.2245−2253.
- Visual and neurological outcome of infants with periventricular leukomalacia Text. / M.S. Scher, V. Dobson, N.A. Carpenter, R.D. Guthrie // Dev. Med Child Neurol.- 1989.- P.353−365.
- White matter hyperintensity signals in psychiatric and nonpsychiatric subjects Text. / F.W. Brown, R.J. Lewine, P.A. Hudgins, S.C. Risch // Am J Psychiatry.- 1992.- P.620−625.
- White matter hyperintensity in neurologically asymptomatic subjects Text. / K. Mineura, H. Sasajima, K. Kikuchi, M. Kowada, N. Tomura, K. Monma, Y. Segawa//Acta Neurol Scand.- 1995.- P.151−156.
- West S.G. Neuropsychiatric lupus Text. / S.G. West // Rheum Dis Clin North Am.- 1994.- Vol.20, № 1.- P. 129−158.
- Wilson W.A. Classification criteria for antiphospholipid syndrome Text. / W.A. Wilson // Rheum Dis Clin North Am.- 2001.- Vol.27, № 3.- P.499−505.
- Wright R.A. Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon’s syndrome Text. / R.A. Wright, E. Kokmen //Mayo Clin.Proc.- 1999.- Vol.74, № 1.- P.57−61.
- Zanardi V.A. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE) Text. / V.A. Zanardi, L.A. Magna, L.T. Costallat // Clin Rheumatol.- 2001.- Vol.20, № 4.- P.245−250.